Philip Morris International Stock in Brief

We've been asking ourselves recently if the market has placed a fair valuation on Philip Morris International. Let's dive into some of the fundamental values of this large-cap Consumer Defensive company to determine if there might be an opportunity here for value-minded investors.

Philip Morris International's Valuation Is in Line With Its Sector Averages:

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company belongs to the Consumer Defensive sector, which has an average price to earnings (P/E) ratio of 24.36. In contrast, Philip Morris International has a trailing 12 month P/E ratio of 18.6 based on its earnings per share of $5.17.

There is an important limit on the usefulness of P/E ratios. Since the P/E ratio is the share price divided by earnings per share, the ratio is determined partially by market sentiment on the stock. Sometimes a negative sentiment translates to a lower market price and therefore a lower P/E ratio -- and there might be good reasons for this negative sentiment.

One of the main reasons not to blindly invest in a company with a low P/E ratio is that it might have low growth expectations. Low growth correlates with low stock performance, so it's useful to factor growth into the valuation process. One of the easiest ways to do this is to divide the company's P/E ratio by its expected growth rate, which results in the price to earnings growth, or PEG ratio.

Philip Morris International's PEG ratio is 1.69, which shows that the stock is overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

The Company May Be Profitable, but Its Balance Sheet Is Highly Leveraged:

2018-02-13 2019-02-07 2020-02-07 2021-02-09 2022-02-11 2023-02-10
Revenue (MM) $28,748 $29,625 $29,805 $28,694 $31,405 $31,762
Gross Margins 64.0% 64.0% 65.0% 67.0% 68.0% 64.0%
Operating Margins 40% 38% 35% 41% 41% 39%
Net Margins 21.0% 27.0% 24.0% 28.0% 28.0% 28.0%
Net Income (MM) $6,035 $7,911 $7,185 $8,056 $9,109 $9,048
Net Interest Expense (MM) -$914 -$665 -$570 -$618 -$628 -$588
Depreciation & Amort. (MM) -$875 -$989 -$964 -$981 -$998 -$1,189
Earnings Per Share $3.89 $5.09 $4.62 $5.17 $5.85 $5.81
EPS Growth n/a 30.85% -9.23% 11.9% 13.15% -0.68%
Diluted Shares (MM) 1,553 1,555 1,556 1,558 1,558 1,557
Free Cash Flow (MM) $10,460 $10,914 $10,942 $10,414 $12,715 $11,880
Capital Expenditures (MM) -$1,548 -$1,436 -$852 -$602 -$748 -$1,077
Net Current Assets (MM) -$31,604 -$31,098 -$31,960 -$33,954 -$31,781 -$48,373
Long Term Debt (MM) $31,334 $26,975 $26,656 $28,168 $24,783 $34,875
Net Debt / EBITDA 2.08 2.04 2.1 1.92 1.67 2.97
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.